Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials

References

• Favier O, Heutte N, Stamatoullas-Bastard A, European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Group and the Groupe d‘Etudes des Lymphomes de l‘Adulte (GELA), et al. Survival after Hodgkin lymphoma: causes of death and excess mortality in patients treated in 8 consecutive trials. Cancer. 2009;115(8):1680–1691.
   PubMed Web of Science ®Google Scholar
• Fobair P, Hoppe RT, Bloom J, et al. Psychosocial problems among survivors of Hodgkin’s disease. J Clin Oncol. 1986;4(5):805–814.
   PubMed Web of Science ®Google Scholar
• Abrahamsen AF, Loge JH, Hannisdal E, et al. Socio-medical situation for long-term survivors of Hodgkin’s disease: a survey of 459 patients treated at one institution. Eur J Cancer. 1998;34(12):1865–1870.
   PubMed Web of Science ®Google Scholar
• van Tulder MW, Aaronson NK, Bruning PF. The quality of life of long-term survivors of Hodgkin’s disease. Ann Oncol. 1994;5(2):153–158.
   PubMed Web of Science ®Google Scholar
• Ng A. Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects. Blood. 2014;124(23):3373–3379.
   PubMed Web of Science ®Google Scholar
• Hodgkin lymphoma incidence statistics [Internet]. Cancer Research UK; 2015. [cited 2021 Sep 30]. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/hodgkin-lymphoma/incidence.
   Google Scholar
• Tracy JK, Falk D, Thompson RJ, et al. Managing the cancer–work interface: the effect of cancer survivorship on unemployment. Cancer Manag Res. 2018;10:6479–6487.
   PubMed Web of Science ®Google Scholar
• Parsons HM, Harlan LC, Lynch CF, et al. Impact of cancer on work and education Among adolescent and young adult cancer survivors. J Clin Oncol. 2012;30(19):2393–2400.
   PubMed Web of Science ®Google Scholar
• Joly F, Henry-Amar M, Arveux P, et al. Late psychosocial sequelae in Hodgkin’s disease survivors: a French population-based case-control study. J Clin Oncol. 1996;14(9):2444–2453.
   PubMed Web of Science ®Google Scholar
• Chen AB, Feng Y, Neuberg D, et al. Employment and insurance in survivors of Hodgkin lymphoma and their siblings: a questionnaire study. Leuk Lymphoma. 2012;53(8):1474–1480.
   PubMed Web of Science ®Google Scholar
• Wettergren L, Björkholm M, Axdorph U, et al. Individual quality of life in long-term survivors of Hodgkin’s lymphoma–a comparative study. Qual Life Res. 2003;12(5):545–554.
   PubMed Web of Science ®Google Scholar
• Pálmarsdóttir R, Kiesbye Øvlisen A, Severinsen MT, et al. Socioeconomic impact of Hodgkin lymphoma in adult patients: a systematic literature review. Leuk Lymphoma. 2019;60(13):3116–3131.
   PubMed Web of Science ®Google Scholar
• Juul SJ, Rossetti S, Kicinski M, et al. Employment situation among long-term Hodgkin lymphoma survivors in Europe: an analysis of patients from nine consecutive EORTC-LYSA trials. J Cancer Surviv. 2022. DOI:10.1007/s11764-022-01305-w
   Google Scholar
• Short PF, Vasey JJ, Tunceli K. Employment pathways in a large cohort of adult cancer survivors. Cancer. 2005;103(6):1292–1301.
   PubMed Web of Science ®Google Scholar
• Horsboel TA, Nielsen CV, Nielsen B, et al. Type of hematological malignancy is crucial for the return to work prognosis: a register-based cohort study. J Cancer Surviv. 2013;7(4):614–623.
   PubMed Web of Science ®Google Scholar
• Aleman BMP, Raemaekers JMM, Tirelli U, European Organization for Research and Treatment of Cancer Lymphoma Group, et al. Involved-field radiotherapy for advanced Hodgkin’s lymphoma. N Engl J Med. 2003;348(24):2396–2406.
   PubMed Web of Science ®Google Scholar
• Carde P, Burgers JM, Henry-Amar M, et al. Clinical stages I and II Hodgkin’s disease: a specifically tailored therapy according to prognostic factors. J Clin Oncol. 1988;6(2):239–252.
   PubMed Web of Science ®Google Scholar
• Carde P, Hagenbeek A, Hayat M, et al. Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin’s disease: the H6 twin randomized trials from the European organization for research and treatment of cancer lymphoma cooperative group. J Clin Oncol. 1993;11(11):2258–2272.
   PubMed Web of Science ®Google Scholar
• Noordijk EM, Carde P, Dupouy N, et al. Combined-modality therapy for clinical stage I or II Hodgkin’s lymphoma: long-term results of the European organisation for research and treatment of cancer H7 randomized controlled trials. J Clin Oncol. 2006;24(19):3128–3135.
   PubMed Web of Science ®Google Scholar
• Somers R, Carde P, Tarayre M, et al. A randomized study in stage IIIB and IV Hodgkin’s disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European organization for research and treatment of cancer lymphoma cooperative group and groupe pierre-et-Marie-Curie cont. J Clin Oncol. 1994;12(2):279–287.
   PubMed Web of Science ®Google Scholar
• Tubiana M, Henry-Amar M, Hayat M, et al. Long-term results of the E.O.R.T.C. randomized study of irradiation and vinblastine in clinical stages I and II of Hodgkin’s disease. Eur J Cancer (1965). 1979;15(5):645–657.
   PubMed Web of Science ®Google Scholar
• Tubiana M, Hayat M, Henry-Amar M, et al. Five-year results of the E.O.R.T.C. randomized study of splenectomy and spleen irradiation in clinical stages I and II of Hodgkin’s disease. Eur J Cancer. 1981;17(3):355–363.
   Web of Science ®Google Scholar
• Thomas J, Fermé C, Noordijk EM, et al. Comparison of 36 gy, 20 gy, or no radiation therapy After 6 cycles of EBVP chemotherapy and complete remission in Early-Stage Hodgkin lymphoma without risk factors: results of the EORT-GELA H9-F intergroup randomized trial. Int J Radiat Oncol Biol Phys. 2018;100(5):1133–1145.
   PubMed Web of Science ®Google Scholar
• Fermé C, Thomas J, Brice P, Groupe d‘Étude des Lymphomes de l‘Adulte, et al. ABVD or BEACOPP baseline along with involved-field radiotherapy in early-stage Hodgkin lymphoma with risk factors: results of the European organisation for research and treatment of cancer (EORTC)–groupe d’Étude des lymphomes de l’Adulte (GELA) H9-U intergroup randomised trial. Eur J Cancer. 2017;81:45–55.
   PubMed Web of Science ®Google Scholar
• Fermé C, Eghbali H, Meerwaldt JH, EORTC-GELA H8 Trial, et al. Chemotherapy plus involved-field radiation in early-stage Hodgkin’s disease. N Engl J Med. 2007;357(19):1916–1927.
   PubMed Web of Science ®Google Scholar
• Flechtner H, Rüffer JU, Henry-Amar M, et al. Quality of life assessment in Hodgkin’s disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC lymphoma cooperative group. Groupe d’Etude des lymphomes de l’Adulte and German Hodgkin study group. Ann Oncol Off J Eur Soc Med Oncol. 1998;9(Suppl 5):S147–s154.
   PubMed Web of Science ®Google Scholar
• van der Kaaij MAE, Heutte N, Meijnders P, et al. Parenthood in survivors of Hodgkin lymphoma: an EORTC-GELA general population case-control study. J Clin Oncol. 2012;30(31):3854–3863.
   PubMed Web of Science ®Google Scholar
• van der Kaaij MAE, Heutte N, Meijnders P, et al. Premature ovarian failure and fertility in long-term survivors of Hodgkin’s lymphoma: a European organisation for research and treatment of cancer lymphoma group and groupe d’Etude des lymphomes de l’Adulte cohort study. J Clin Oncol. 2012;30(3):291–299.
   PubMed Web of Science ®Google Scholar
• van der Kaaij MAE, Heutte N, Le Stang N, et al. Gonadal function in males after chemotherapy for early-stage Hodgkin’s lymphoma treated in four subsequent trials by the European organisation for research and treatment of cancer: EORTC lymphoma group and the groupe d’Etude des lymphomes de l’Adulte. J Clin Oncol. 2007;25(19):2825–2832.
   PubMed Web of Science ®Google Scholar
• van der Kaaij MAE, van Echten-Arends J, Heutte N, et al. Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA lymphoma group cohort study. Hum Reprod Oxf Engl. 2014;29(3):525–533.
   PubMed Web of Science ®Google Scholar
• Maraldo MV, Giusti F, Vogelius IR, European Organisation for Research and Treatment of Cancer (EORTC) Lymphoma Group, et al. Cardiovascular disease after treatment for Hodgkin’s lymphoma: an analysis of nine collaborative EORTC-LYSA trials. Lancet Haematol. 2015;2(11):e492-502–e502.
   PubMed Web of Science ®Google Scholar
• Busson R, van der Kaaij M, Mounier N, et al. Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study. Health Qual Life Outcomes. 2019;17(1):115.
   PubMed Web of Science ®Google Scholar
• Harrell F. Regression modelling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001.
   Google Scholar
• Lin D, Wei LJ, Ying Z. Checking the cox model with cumulative sums of martingale-based residuals. Biometrika. 1993;80(3):557–572.
   Web of Science ®Google Scholar
• Brauer ER, Pieters HC, Ganz PA, et al. “From snail mode to rocket ship mode”: adolescents and young adults’ experiences of returning to work and school AFTER hematopoietic cell transplantation. J Adolesc Young Adult Oncol. 2017;6(4):551–559.
   PubMed Web of Science ®Google Scholar
• Zhang W. Radiotherapy in early stage classical Hodgkin lymphoma: past, present and future. Chin Clin Oncol. 2015;4(1):6–6.
   PubMedGoogle Scholar
• The social security system in the Netherlands [Internet]. Expatica Netherlands [cited 2022 Nov 22]. Available from: https://www.expatica.com/nl/living/gov-law-admin/social-security-in-the-netherlands-100578/.
   Google Scholar
• French social security – and how to claim benefits [Internet]. Expatica France [cited 2022 Nov 22]. Available from: https://www.expatica.com/fr/living/gov-law-admin/french-social-security-101168/.
   Google Scholar
• Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77(2):109–130.
   PubMed Web of Science ®Google Scholar
• Schultz PN, Beck ML, Stava C, et al. Cancer survivors. Work related issues. AAOHN J Off J Am Assoc Occup Health Nurses. 2002;50(5):220–226.
   PubMedGoogle Scholar
• Hensel M, Egerer G, Schneeweiss A, et al. Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation. Ann Oncol. 2002;13(2):209–217.
   PubMed Web of Science ®Google Scholar
• Carlsen K, Dalton SO, Frederiksen K, et al. Cancer and the risk for taking early retirement pension: a Danish cohort study. Scand J Public Health. 2008;36(2):117–125.
   PubMed Web of Science ®Google Scholar
• Carlsen K, Dalton SO, Diderichsen F, Danish Cohort Study, et al. Risk for unemployment of cancer survivors: a Danish cohort study. Eur J Cancer. 2008;44(13):1866–1874.
   PubMed Web of Science ®Google Scholar
• Horsboel TA, De Thurah A, Nielsen B, et al. Factors associated with work outcome for survivors from haematological malignancies – a systematic literature review. Eur J Cancer Care. 2012;21(4):424–435.
   PubMed Web of Science ®Google Scholar
• Gender statistics [Internet] [cited 2021 Oct 15]. Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Gender_statistics.
   Google Scholar
• Marino P, Sagaon TL, Laetitia M, et al. Sex differences in the return-to-work process of cancer survivors 2 years after diagnosis: results from a large French population-based sample. J Clin Oncol. 2013;31(10):1277–1284.
   PubMed Web of Science ®Google Scholar
• Behringer K, Goergen H, Müller H, et al. Cancer-Related fatigue in patients With and survivors of Hodgkin lymphoma: the impact on treatment outcome and social reintegration. J Clin Oncol. 2016;34(36):4329–4337.
   PubMed Web of Science ®Google Scholar
• Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci. 2003;58(1):82–91.
   PubMed Web of Science ®Google Scholar
• Taskila T, Lindbohm ML. Factors affecting cancer survivors’ employment and work ability. Acta Oncol. 2007;46(4):446–451.
   PubMed Web of Science ®Google Scholar
• Tang P, Loberiza FR. Are lymphoma survivors really at higher risk for unemployment/underemployment? Leuk Lymphoma. 2012;53(8):1437–1438.
   PubMed Web of Science ®Google Scholar
• Hartung TJ, Sautier LP, Scherwath A, et al. Return to work in patients with hematological cancers 1 year after treatment: a prospective longitudinal study. Oncol Res Treat. 2018;41(11):697–701.
   PubMed Web of Science ®Google Scholar
• Bradley CJ, Bednarek HL. Employment patterns of long-term cancer survivors. Psychooncology. 2002;11(3):188–198.
   PubMed Web of Science ®Google Scholar
• Main DS, Nowels CT, Cavender TA, et al. A qualitative study of work and work return in cancer survivors. Psychooncology. 2005;14(11):992–1004.
   PubMed Web of Science ®Google Scholar
• Leuteritz K, Friedrich M, Sender A, et al. Return to work and employment situation of young adult cancer survivors: results from the adolescent and young Adult-Leipzig study. J Adolesc Young Adult Oncol. 2021;10(2):226–233.
   PubMed Web of Science ®Google Scholar
• Kornblifh AB, Anderson J, Cella DF, et al. Hodgkin disease survivors at increased risk for problems in psychosocial adaptation. Cancer. 1992;70(8):2214–2224.
   PubMed Web of Science ®Google Scholar
• Duijts SFA, van Egmond MP, Spelten E, et al. Physical and psychosocial problems in cancer survivors beyond return to work: a systematic review. Psychooncology. 2014;23(5):481–492.
   PubMed Web of Science ®Google Scholar
• Liu L, Giusti F, Schaapveld M, et al. Survival differences between patients with Hodgkin lymphoma treated inside and outside clinical trials. A study based on the EORTC-Netherlands cancer registry linked data with 20 years of follow-up. Br J Haematol. 2017;176(1):65–75.
   PubMed Web of Science ®Google Scholar
• Peteet JR. Cancer and the meaning of work. Gen Hosp Psychiatry. 2000;22(3):200–205.
   PubMed Web of Science ®Google Scholar